MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

164.58 -1.08 (-0.65%)
Streaming Delayed Price Updated: 10:36 AM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 48,861
Open 165.15
Bid (Size) 163.55 (200)
Ask (Size) 164.69 (100)
Prev. Close 165.66
Today's Range 163.85 - 165.58
52wk Range 102.97 - 182.52
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Volatile Stock to Target This Week and 2 We Turn Down
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
News headline image
Why Repligen (RGEN) Stock Is Trading Up Today
Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 5.7% in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate... 
Via StockStory
Topics Artificial Intelligence Economy Stocks

Performance

YTD
+15.1%
+15.1%
1 Month
-4.2%
-4.2%
3 Month
+35.3%
+35.3%
6 Month
+32.5%
+32.5%
1 Year
+12.9%
+12.9%

More News

Read More
News headline image
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Earnings Scheduled For October 28, 2025 ↗
Via Benzinga
News headline image
3 Cash-Producing Stocks We Approach with Caution
Via StockStory
News headline image
Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN)
Via StockStory
News headline image
5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call
Via StockStory
Topics Earnings
News headline image
3 Hyped Up Stocks with Open Questions
Via StockStory
News headline image
RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset
Via StockStory
News headline image
Why Repligen (RGEN) Shares Are Trading Lower Today
Via StockStory
Topics Economy Government World Trade
News headline image
Repligen Corp (NASDAQ:RGEN) Posts Strong Q3 2025 Results, Beating Revenue and EPS Estimates ↗
Via Chartmill
News headline image
Repligen’s (NASDAQ:RGEN) Q3 Sales Beat Estimates
Via StockStory
Topics Earnings
News headline image
Repligen Earnings: What To Look For From RGEN
Via StockStory
Topics Artificial Intelligence
News headline image
3 Inflated Stocks with Questionable Fundamentals
Via StockStory
News headline image
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Government World Trade
News headline image
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
News headline image
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
What 8 Analyst Ratings Have To Say About Repligen ↗
Via Benzinga
News headline image
Why Is Repligen (RGEN) Stock Soaring Today
Via StockStory
Topics Government
News headline image
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government
News headline image
1 Volatile Stock to Target This Week and 2 Facing Challenges
Via StockStory
News headline image
3 Reasons to Sell RGEN and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
News headline image
Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)
Via StockStory
News headline image
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
Via Benzinga
News headline image
Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 164.58
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 12/26/25 10:36 AM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 9.16B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story